Drug intelligence / Profile preview

Cosmetic CBD cream

Development stage: Preclinical
Lead developer: BioNanoSim
Modality: Small Molecules, Nanoparticles → Drug Delivery Systems
Administration: Topical

Overview

Cosmetic CBD cream is a topical formulation of cannabidiol (CBD) developed by BioNanoSim using its proprietary nanotechnology platform. Positioned within the company's "Non-Pharma Track," this product is designed for cosmetic applications, leveraging the known anti-inflammatory, antioxidant, and skin-conditioning properties of CBD. The use of BioNanoSim's nano-delivery technology is intended to enhance the penetration and stability of the cannabinoid within the skin layers. It is primarily aimed at the consumer skincare market for general skin health and appearance enhancement.

Other names: cannabidiolCBD creamtopical CBD formulationCosmetic CBD cream

Targets

CNR1 (Cannabinoid receptor 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on Cosmetic CBD cream.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cosmetic CBD cream.